Biochem/physiol Actions
Cell permeable: no
Reversible: no
Product does not compete with ATP.
Primary TargetOsteoclast-mediated bone resorption
Target IC50: 100 nM inhibiting invasion, adhesion, and migration of PC-3 prostate cancer cells
General description
A non-amino, chloro-containing bisphosphonate that acts as a potent inhibitor of osteoclast-mediated bone resorption. It is metabolized into a non-hydrolyzable ATP analog in osteoclasts and macrophages, and induces apoptosis by inhibiting mitochondrial function. An efficient metal chelator that inhibits invasion, adhesion, and migration of PC-3 prostate cancer cells (IC50 = 100 nM).
A non-amino, chloro-containing, bisphosphonate that acts as a potent inhibitor of osteoclast-mediated bone resorption. Metabolized to a non-hydrolyzable ATP analog in osteoclasts and macrophages that induces apoptosis by inhibiting mitochondrial function. An efficient metal chelator that inhibits invasion, adhesion and migration of PC-3 prostate cancer cells (IC50 = 100 nM).
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Lehenkari, P.P., et al. 2002. Mol. Pharmacol.61, 1255.Virtanen, S.S., et al. 2002. Cancer Res.62, 2708.Smith, R., et al. 1971. Lancet1, 945.Fleisch, H., et al. 1969. Nature223, 211.
Packaging
10 mg in Plastic ampoule
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: